X
40.64
0.03 (0.07%)
| Penutupan Terdahulu | 40.61 |
| Buka | 40.62 |
| Jumlah Dagangan | 313,227 |
| Purata Dagangan (3B) | 756,925 |
| Modal Pasaran | 3,140,456,192 |
| Harga / Jualan (P/S) | 465.35 |
| Harga / Buku (P/B) | 6.12 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Nov 2025 |
| Margin Operasi (TTM) | -969.84% |
| EPS Cair (TTM) | -3.22 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.23% |
| Nisbah Semasa (MRQ) | 17.66 |
| Aliran Tunai Operasi (OCF TTM) | -196.85 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -128.49 M |
| Pulangan Atas Aset (ROA TTM) | -22.03% |
| Pulangan Atas Ekuiti (ROE TTM) | -31.60% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Xenon Pharmaceuticals Inc. | Menaik | Menaik |
AISkor Stockmoo
2.1
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 2.13 |
|
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.14% |
| % Dimiliki oleh Institusi | 103.51% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (JP Morgan, 47.64%) | Beli |
| Median | 55.00 (35.34%) | |
| Rendah | 44.00 (Wells Fargo, 8.27%) | Beli |
| Purata | 54.40 (33.86%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 39.41 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JP Morgan | 18 Nov 2025 | 60.00 (47.64%) | Beli | 40.61 |
| Needham | 04 Nov 2025 | 55.00 (35.33%) | Beli | 39.09 |
| RBC Capital | 04 Nov 2025 | 58.00 (42.72%) | Beli | 39.09 |
| Wells Fargo | 04 Nov 2025 | 44.00 (8.27%) | Beli | 39.09 |
| Chardan Capital | 07 Oct 2025 | 55.00 (35.33%) | Beli | 39.16 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |